JAMA Neurol:骨密度与颅内动脉瘤风险

2017-10-17 zhangfan MedSci原创

研究认为,骨密度与颅内动脉瘤存在较高的相关性,颅内动脉瘤与骨脆性具有共同的病理生理基础

细胞外基质的完整性与颅内动脉瘤和骨脆性密切相关。一般认为由于性激素的差异,颅内动脉瘤和骨质疏松症女性的发病比例较高。近日研究人员考察了骨密度与颅内动脉瘤发病率之间的关系。

在这项横断面研究中,14328名参与者进行了脑磁共振血管造影和骨密度测量,其中12785名患者纳入最终的数据分析。研究采用多因素逻辑回归和线性回归的方法来检查骨密度值与颅内动脉瘤的相关性。二次分析,重点考察骨密度降低风险较高的绝经后女性和50岁以上男性(N = 8722)。

12785名患者中,女性占56.6%,平均年龄54.8岁,共检出颅内动脉瘤472例(3.7%),骨密度降低增加了患者颅内动脉瘤风险。研究发现,骨密度最高人群相比于最低人群,其腰椎、颈椎以及髋关节骨密度比值比分别为1.30、1.30和1.27。调整年龄、性别和血管危险因素后,腰椎骨密度最低人群增加对数变换后的动脉瘤风险 (β 0.196;SE 0.047)。二次分析显示,该相关性确定且T值较低(<-1 SD),调整后与多发性动脉瘤有关(OR,1.84;95% CI,1.05-3.30) 。

研究认为,骨密度与颅内动脉瘤存在较高的相关性,颅内动脉瘤与骨脆性具有共同的病理生理基础。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000138, encodeId=6d442000138d3, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jun 18 02:04:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253713, encodeId=adbe253e13d4, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Oct 17 12:47:13 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253701, encodeId=ef34253e017a, content=好好努力学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Oct 17 12:08:42 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253693, encodeId=4bc4253693d1, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Oct 17 11:54:41 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2018-06-18 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2000138, encodeId=6d442000138d3, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jun 18 02:04:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253713, encodeId=adbe253e13d4, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Oct 17 12:47:13 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253701, encodeId=ef34253e017a, content=好好努力学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Oct 17 12:08:42 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253693, encodeId=4bc4253693d1, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Oct 17 11:54:41 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-17 清风拂面

    谢谢分享.学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2000138, encodeId=6d442000138d3, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jun 18 02:04:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253713, encodeId=adbe253e13d4, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Oct 17 12:47:13 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253701, encodeId=ef34253e017a, content=好好努力学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Oct 17 12:08:42 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253693, encodeId=4bc4253693d1, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Oct 17 11:54:41 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-17 忠诚向上

    好好努力学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2000138, encodeId=6d442000138d3, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jun 18 02:04:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253713, encodeId=adbe253e13d4, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Oct 17 12:47:13 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253701, encodeId=ef34253e017a, content=好好努力学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Oct 17 12:08:42 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=253693, encodeId=4bc4253693d1, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Tue Oct 17 11:54:41 CST 2017, time=2017-10-17, status=1, ipAttribution=)]
    2017-10-17 tanxingdoctor

    学习啦!谢谢分享

    0

相关资讯

J Periodontal Res:慢性牙周炎患者骨质疏松的风险增加:一项台湾人群的队列研究

慢性牙周炎是一种骨质破坏性炎症性疾病,对健康有不利影响,与骨质疏松症可能相关。一些研究检测了慢性牙周炎与骨质疏松之间可能的关系;然而,仍然没有确定的结果。这项纵向随访研究通过使用基于人群的台湾健康保险数据,研究慢性牙周炎患者出现骨质疏松症的可能的风险。

J Periodontol:通过立体显微镜观察骨髓标本以评估种植体植入位点的骨型:与使用牙科放射学评估进行比较

研究的目的是确定使用立体显微镜对手术获得的骨髓标本的骨质量评估是否能可靠地确定种植体植入部位的骨质量。

JAMA Pediatr:预防骨折——青少年身高与骨密度增长速度的差异研究

儿童时期,身高的增长大大超过了骨矿物质含量的增加导致儿童骨折风险增加。在儿童期身高与成年期相差较少但骨密度含量却较低,因此应强化儿童以及青少年期的骨密度管理。

JCEM:抗逆转录病毒疗法对早期感染HIV的青年人骨骼和肾功能的长期影响

HIV抗逆转录病毒(antiretroviral,ARV)疗法会造成肾毒性和骨髓毒性,但关于成人从出生即暴露于ARV药物的累积效应的报道却很少。因此,研究人员前瞻性评估了终身HIV和广泛ARV暴露的青年人的肾及骨骼健康情况。研究人员对出生即感染HIV的青年人(n = 65)的骨密度(BMD,通过双能x线骨密度检测术测得)、骨转移和肾功能与相匹配的健康对照组(n = 23)进行了横断面对比,同时,在

Int J Cardiol:长期使用低剂量阿司匹林与一般人群骨密度较低无关!

长期使用低剂量阿司匹林与一般人群较低的BMD无关。 因此,以往研究中阿斯匹林使用者观察到的骨折风险增加更可能是阿司匹林使用和骨折常见原因的结局,而不是阿司匹林对BMD的直接影响。

J Clin Endocrinol Metab:骨密度不变 胰岛素抵抗与骨几何结构相关?

2017年6月,发表在《J Clin Endocrinol Metab》的一项由比利时科学家进行的研究,发现了在骨量峰值年龄的非糖尿病男性队列中,胰岛素抵抗与骨小梁和皮质骨大小负相关。